A Randomized Controlled Trial Comparing Intradermal vs. Intramuscular Trivalent Inactivated Influenza Vaccine in Adult Solid Organ Transplant Recipients.
Phase of Trial: Phase III
Latest Information Update: 07 Nov 2015
At a glance
- Drugs Influenza virus vaccine (Primary) ; GSK 1536489A
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 07 Nov 2015 Results published in the Vaccine
- 19 Aug 2013 Status changed from active, no longer recruiting to completed.
- 20 Apr 2012 Planned end date changed from 1 May 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.